Literature DB >> 27404977

Sociodemographic and access-related correlates of health-care utilization among African American injection drug users: The BESURE study.

Allysha C Maragh-Bass1, Christine Powell2, Ju Park2, Colin Flynn3, Danielle German4.   

Abstract

Persons who inject drugs (PWID) may have less access to, and utilization of, health-care services, and African American PWID may be less likely than other racial groups to utilize health care in the United States. The present study evaluated the prevalence of health-care utilization (HCU) among a cohort of African American PWID in Baltimore. Data were from the 2012 Baltimore National HIV Behavioral Surveillance study. Participants were adult PWID and recruited using respondent-driven sampling (RDS). They completed a comprehensive sociobehavioral survey and voluntary HIV test with trained study interviewers. Analyses included descriptive and bivariate statistics to examine the prevalence of HCU, defined as seeing a health-care provider in the past year. Poisson regression assessed correlates of HCU. Participants were 61% male; 23% self-reported HIV seropositivity. Nearly 90% reported unemployment and/or disability; HCU prevalence was 85%. Significant negative correlates of HCU included age and higher injection frequency; positive correlates included previous incarceration and moderate financial stability. Interaction analyses showed unemployed publicly insured individuals had 30% higher HCU than unemployed and uninsured individuals (χ2 = 2.52; p < .05). There is a need to improve health-care utilization among PWID. High prevalence of disability was still found, despite insurance coverage and access to care in this population. While the recent Affordable Care Act has increased health-care coverage and access, our results suggest that is only a first step to improving health outcomes among PWID; targeted intervention to integrate these individuals is still needed.

Entities:  

Keywords:  African Americans; HIV/AIDS; health disparities; health-care utilization; injection drug use

Mesh:

Year:  2016        PMID: 27404977     DOI: 10.1080/15332640.2016.1196629

Source DB:  PubMed          Journal:  J Ethn Subst Abuse        ISSN: 1533-2640            Impact factor:   1.507


  5 in total

1.  Health insurance coverage is associated with access to substance use treatment among individuals with injection drug use: Evidence from a 12-year prospective study.

Authors:  Kenneth A Feder; Noa Krawczyk; Ramin Mojtabai; Rosa M Crum; Gregory Kirk; Shruti H Mehta
Journal:  J Subst Abuse Treat       Date:  2018-08-28

2.  Access to healthcare insurance and healthcare services among syringe exchange program clients in Massachusetts: qualitative findings from health navigators with the iDU ("I do") Care Collaborative.

Authors:  Thomas J Stopka; Marguerite Hutcheson; Ashley Donahue
Journal:  Harm Reduct J       Date:  2017-05-18

3.  Value of Packaged Testing for Sexually Transmitted Infections for Persons who Inject Drugs Hospitalized With Serious Injection-Related Infections.

Authors:  Laura R Marks; Hilary Reno; Stephen Y Liang; Evan S Schwarz; David B Liss; Linda Jiang; Nathanial S Nolan; Michael J Durkin
Journal:  Open Forum Infect Dis       Date:  2021-11-11       Impact factor: 3.835

4.  Hepatitis C treatment uptake among people who inject drugs in the oral direct-acting antiviral era.

Authors:  Oluwaseun Falade-Nwulia; Rachel E Gicquelais; Jacquie Astemborski; Sean D McCormick; Greg Kirk; Mark Sulkowski; David L Thomas; Shruti H Mehta
Journal:  Liver Int       Date:  2020-10       Impact factor: 8.754

5.  Unweighted regression models perform better than weighted regression techniques for respondent-driven sampling data: results from a simulation study.

Authors:  Lisa Avery; Nooshin Rotondi; Constance McKnight; Michelle Firestone; Janet Smylie; Michael Rotondi
Journal:  BMC Med Res Methodol       Date:  2019-10-29       Impact factor: 4.615

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.